Login / Signup

Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients-authors' reply.

Stanislas PolClovis Luzivika NzingaFabrice Carrat
Published in: Alimentary pharmacology & therapeutics (2021)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • hepatitis b virus
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • combination therapy